K

KBI Biopharma

CDMO delivering cell line development

Network Engineer

Network Engineering & AdministrationConfirmed live in the last 24 hours
Full-timeBoulder, CO, USA

About the Job

Requirements

  • Proficiency in configuring and troubleshooting network devices, including routers, switches, and firewalls.
  • Understanding of Layer 2 technologies, including VLANs, STP, and trunking.
  • Understanding of Layer 3 technologies, including VRF, VRF-Lite, and SVI.
  • Understanding of VPN technologies, including SD-WAN, IPSec, and route-based VPNs.
  • Knowledge of routing protocols such as BGP, ISIS, OSPF, and EIGRP.
  • Familiarity with basic network security principles, including access control lists and VPNs.
  • Experience with network management and monitoring tools such as SNMP and Wireshark.
  • Understanding of IPv6.
  • Understanding of operating systems such as Windows and Linux, virtualization, and cloud technologies including AWS and Azure.
  • Capacity to analyze complex problems and develop solutions.
  • Ability to document technical procedures, system configurations, and project plans.
  • Bachelor's degree in Computer Science, Information Technology, or a related field, with a minimum of 3 years of experience.
  • CCNA certification is required.

Responsibilities

  • Design and manage LAN/WAN, wireless, and SD-WAN infrastructure across laboratory, manufacturing, and corporate spaces.
  • Maintain IT/OT network segmentation between corporate, laboratory, and manufacturing networks.
  • Configure and maintain network devices such as switches, routers, and firewalls.
  • Troubleshoot network connectivity issues and resolve basic network problems.
  • Assist in implementing network security measures.

Desired Qualifications

  • CCNP certification is preferred.

About the Company

KBI Biopharma

CDMO delivering cell line development

KBI Biopharma is a CDMO that accelerates the development of biological medicines by providing rapid cell line generation and process development for preclinical programs. It uses established mammalian and microbial expression systems (such as CHO K1, CHO S, CHO DG44, HEK293, and DXB11 E. coli) to create production cell lines and develop integrated manufacturing processes. Compared with competitors, it wins on speed, end-to-end capability, and flexibility across multiple platforms to move projects quickly from discovery to preclinical milestones for a diverse client base. Its goal is to reduce risk, shorten development timelines, and expand global access to life-saving biologic therapies.

Company size
1,001-5,000
Company stage
Late Stage VC
Total funding
$109.5M
Headquarters
Durham, NC
Founded
1996

Recently Posted Jobs

Explore more opportunities at KBI Biopharma

See more jobs